Skyscape Web Viewer : The Maudsley Prescribing Guidelines in Psychiatry : Main Index

View All
Gabapentin tardive dyskinesia borderline personality disorder use in patients with hepatic impairment
gabapentinoids (GABA analogues), addiction/physical dependence and withdrawal
Galantamine alzheimerâ™s disease mild cognitive impairment
Gambling disorder
gamma-hydroxybutyrate (GHB) and gamma-butyrolactone dependence unplanned withdrawal withdrawal syndrome planned elective withdrawal withdrawal management
Gastrointestinal disorders, drug safety in older patients/dementia
Gastrointestinal hypomotility, clozapine-induced
Gastrointestinal necrosis
General Guidelines
generalised anxiety disorder (GAD) pregabalin SSRIs/SNRIs NICE guidelines specific drugs used valproate treatment
Generalised seizures, severe alcohol withdrawal
General recommendations for prescribing intramuscular clozapine
Genetic testing for clozapine treatment
Genetic testing for treatment benign ethnic neutropenia agranulocytosis Genetic testing for clozapine treatment
genitourinary symptoms of menopause (GSM) 857
Ginkgo biloba Alternatives to clozapine Optimising clozapine treatment Dementia Treatment of tardive dyskinesia
glomerular filtration rate (GFR), estimation for renal impairment assessment
Galactorrhea
gamma-glutamyl transferase (GGT), psychotropic agent effects
gastrointestinal bleeding, SSRI risks
Gastrointestinal disturbances, antiretrovirals
Gastrointestinal irritant drugs, increased risk of bleeding in hepatic impairment
gastro-oesophageal reflux disease (GERD) 220
General Medical Council, UK, guidelines for prescribers, medical conditions and safe driving
Genetics of cytochrome function
Gestational diabetes, antipsychotics risk
Glucose homeostasis antidepressant effects SSRIs improving control
Glucose homeostasis effects
Glucose tolerance impairment, antipsychotic-related Diabetes and impaired glucose tolerance Switching antipsychotics
Glucose tolerance impairment association